Replimune News and Activities

Presence

Replimune develops cancer immunotherapy medicines. Its services and products include oncolytic therapy research, clinical development, and drug candidates for hospitals, cancer specialists, and patients with solid tumors.

Replimune products and services overview:

  • Cancer immunotherapy
  • Oncolytic therapies
  • Drug development
  • Clinical research

Revenue: ~$20 million

Employees: 300

Headquarters: Woburn, United States (USA)


Replimune is one of the...

Replimune is a company listed under the stock ticker REPL (US).

Executives

View the org chart displaying its 31 main executives

Most searched biographies at Replimune
Popular executive movements at Replimune
  • Chris Sarchi, Chief Commercial Officer, has left the company  (posted on June 1 2026).

Create your alert
to follow the executive moves at Replimune.

Biotechnology

Replimune has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry

News

Press releases by Replimune
Social media about Replimune

Get in Touch

Call Replimune at +1 617...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Data & API
Executives
Companies
The Official Board